The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic significance of imaging-detected extranodal extension (iENE) in pathological ENE-negative head and neck squamous cell carcinoma.
 
Ryo Kuboki
No Relationships to Disclose
 
Tomohiro Enokida
Honoraria - Bayer; Merck; MSD
 
Hirofumi Kuno
Speakers' Bureau - Bayer Yakuhin; Canon Medical System; Fuji Pharma
Research Funding - Canon Medical System (Inst)
 
Takashi Hiyama
No Relationships to Disclose
 
Takuma Kishida
No Relationships to Disclose
 
Shingo Sakashita
Consulting or Advisory Role - Chugai Pharma
Speakers' Bureau - DAIICHI SANKYO COMPANY, LIMITED (I)
 
Susumu Okano
Speakers' Bureau - Bristol-Myers Squibb Japan; Meiji Seika Kaisha; Merck Serono; MSD; Ono Pharmaceutical
 
Takao Fujisawa
Honoraria - Amelief; AstraZeneca; Merck; Merck Serono
 
Nobukazu Tanaka
No Relationships to Disclose
 
Yuta Hoshi
No Relationships to Disclose
 
Ryutaro Onaga
Honoraria - Bayer; Canon Medical System (I); EA Pharma (I); Eisai; Fujifilm (I); Olympus Medical Systems (I); Ono Yakuhin
Speakers' Bureau - Bayer; Eisai; Ono Yakuhin
Travel, Accommodations, Expenses - Bayer; Eisai; Lilly Japan; Ono Yakuhin
 
Takeshi Shinozaki
Honoraria - Rakuten Medical Japan
Research Funding - Rakuten Medical
 
Toshifumi Tomioka
No Relationships to Disclose
 
Wataru Okano
No Relationships to Disclose
 
Takashi Kitani
No Relationships to Disclose
 
Sadamoto Zenda
No Relationships to Disclose
 
Kazuto Matsuura
Honoraria - Abbott Japan; DAIICHI SANKYO COMPANY; Kyorin
 
Genichiro Ishii
No Relationships to Disclose
 
Takahiro Asakage
No Relationships to Disclose
 
Makoto Tahara
Honoraria - Bayer; Bristol-Myers Squibb; Eisai; Lilly; Merck Serono; MSD; Novartis; Ono Pharmaceutical
Consulting or Advisory Role - Astellas Pharma; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Genmab; GlaxoSmithKline; Janssen; Lilly; Merck KGaA; MSD; Nanobiotix; Ono Pharmaceutical; Pfizer
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); Nanobiotix (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst)